[go: up one dir, main page]

MX2019000749A - Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida. - Google Patents

Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida.

Info

Publication number
MX2019000749A
MX2019000749A MX2019000749A MX2019000749A MX2019000749A MX 2019000749 A MX2019000749 A MX 2019000749A MX 2019000749 A MX2019000749 A MX 2019000749A MX 2019000749 A MX2019000749 A MX 2019000749A MX 2019000749 A MX2019000749 A MX 2019000749A
Authority
MX
Mexico
Prior art keywords
tetramethyltetrahydro
dimethylcyclohex
pyran
carboxamide
cyano
Prior art date
Application number
MX2019000749A
Other languages
English (en)
Other versions
MX384614B (es
Inventor
E Fawzy Nagy
Breslin David
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2019000749A publication Critical patent/MX2019000749A/es
Publication of MX384614B publication Critical patent/MX384614B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente descripcion describe formas cristalinas de 4-ciano-N-[2-(4,4-dimetilciclohex-1-en-1-il)-6- 2,2,6,6-tetrametiltetrahidro-2H-piran-4-il)piridina-3-il]-1H-imid azol-2-carboxamida.
MX2019000749A 2016-07-18 2017-07-17 Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il)-6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-imidazol-2-carboxamida. MX384614B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662363622P 2016-07-18 2016-07-18
PCT/US2017/042310 WO2018017444A1 (en) 2016-07-18 2017-07-17 Crystalline forms of 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide

Publications (2)

Publication Number Publication Date
MX2019000749A true MX2019000749A (es) 2019-08-29
MX384614B MX384614B (es) 2025-03-14

Family

ID=59631847

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019000749A MX384614B (es) 2016-07-18 2017-07-17 Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il)-6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-imidazol-2-carboxamida.
MX2021006739A MX2021006739A (es) 2016-07-18 2019-01-17 Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021006739A MX2021006739A (es) 2016-07-18 2019-01-17 Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida.

Country Status (16)

Country Link
US (1) US10314821B2 (es)
EP (1) EP3484872B1 (es)
JP (1) JP2019521159A (es)
KR (1) KR20190026910A (es)
CN (1) CN109952296A (es)
AR (1) AR109079A1 (es)
AU (1) AU2017299506B2 (es)
BR (1) BR112019000982A2 (es)
CA (1) CA3031230A1 (es)
EA (1) EA201990320A1 (es)
ES (1) ES2935647T3 (es)
MA (1) MA45685A (es)
MX (2) MX384614B (es)
TW (1) TWI752980B (es)
UY (1) UY37338A (es)
WO (1) WO2018017444A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023548384A (ja) * 2020-10-30 2023-11-16 アテネックス アールアンドディ エルエルシー Ｈｍ３０１８１メシル酸塩の多形

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
EP2215482A2 (en) * 2007-10-31 2010-08-11 Janssen Pharmaceutica N.V. Biomarker for assessing response to fms treatment
JOP20180012A1 (ar) * 2012-08-07 2019-01-30 Janssen Pharmaceutica Nv عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
WO2014151253A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide for the treatment of hodgkin's lymphoma
US9611259B2 (en) * 2013-03-15 2017-04-04 Janssen Pharmaceutica Nv Substituted pyridine derivatives useful as C-FMS kinase inhibitors

Also Published As

Publication number Publication date
AU2017299506B2 (en) 2021-08-05
ES2935647T3 (es) 2023-03-08
EP3484872B1 (en) 2022-11-30
TW201808941A (zh) 2018-03-16
MX2021006739A (es) 2021-07-15
CN109952296A (zh) 2019-06-28
EA201990320A1 (ru) 2019-06-28
US10314821B2 (en) 2019-06-11
TWI752980B (zh) 2022-01-21
AU2017299506A1 (en) 2019-02-07
CA3031230A1 (en) 2018-01-25
EP3484872A1 (en) 2019-05-22
BR112019000982A2 (pt) 2019-05-14
WO2018017444A1 (en) 2018-01-25
AR109079A1 (es) 2018-10-24
UY37338A (es) 2018-01-31
MX384614B (es) 2025-03-14
JP2019521159A (ja) 2019-07-25
KR20190026910A (ko) 2019-03-13
MA45685A (fr) 2019-05-22
US20180133197A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
PL3577110T3 (pl) Związki podstawione 8-oksetan-3-ylo-3,8-diazabicyklo[3.2.1]oktan-3-ylem jako inhibitory hiv
EP3602933C0 (en) Semi-persistent csi feedback over pusch
LT3523301T (lt) Pakeistieji pirazolo[1,5-a]piridino junginiai kaip ret kinazės slopikliai
CO2017006099A2 (es) Formas sólidas de un inhibidor ask1
EP3452481A4 (en) IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
IL252089B (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
DK4356969T3 (da) Smeltede tricykliske pyridazinonforbindelser, der er nyttige til behandling af orthomyxovirusinfektioner
MA45554A (fr) Fusions de binucléase optimisées.
LT3402782T (lt) 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai
EP3508487A4 (en) PYRAZOLO [1,5-A] PYRIMIDINE COMPOUND
DK3400225T3 (da) Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner
ES1175583Y (es) Portero electronico accesible.
EP3478563A4 (en) TRACTOR PROXIMITY CONTROL
CL2018003048S1 (es) Herramienta de medición para el cuerpo, prenda de vestir.
DK3459953T3 (da) Hidtil ukendt 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-on-derivat
DK3397621T3 (da) Fremgangsmåde til fremstilling af 1,1,3-trioxo-1,2-benzothiazol-6-carboxamid
PL3169666T3 (pl) Podstawione pochodne azaspiro(4,5)dekanu
EP3712139A4 (en) TETRAHYDROISOXAZOLO [4,3-C] PYRIDINE ANTI-HBV COMPOUNDS
CL2018003051S1 (es) Herramienta de medición para el cuerpo, prenda de vestir.
MX2019000749A (es) Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida.
DK3397620T3 (da) Fremgangsmåde til fremstilling af 1,1,3-Trioxo-1,2-benzothiazol-6-carboxamid
UY37339A (es) Formas de sal de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il)-6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1himidazol-2-carboxamida y composiciones que las contienen
CL2018003049S1 (es) Herramienta de medición para el cuerpo, prenda de vestir.
CL2018003053S1 (es) Herramienta de medición para el cuerpo, prenda de vestir.